Hitchwood Capital Management LP Exact Sciences Corp Transaction History

Hitchwood Capital Management LP

8 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2019 Feb 14, 2020	SELL	$77.66 - $99.74 $11.3 Million - $14.5 Million	-145,000 Closed	0 $0
Q3 2019 Nov 14, 2019	SELL	$90.37 - $122.49 $4.07 Million - $5.51 Million	-45,000 Reduced 23.68%	145,000 $13.1 Million
Q2 2019 Aug 14, 2019	SELL	$89.51 - $118.04 $3.13 Million - $4.13 Million	-35,000 Reduced 15.56%	190,000 $22.4 Million
Q1 2019 May 15, 2019	BUY	$61.98 - $96.5 $13.9 Million - $21.7 Million	225,000 New	225,000 $19.5 Million
Q4 2018 Feb 14, 2019	SELL	$56.04 - $82.66 $40.6 Million - $59.9 Million	-725,000 Closed	0 $0
Q3 2018 Nov 14, 2018	BUY	$48.29 - $80.6 $20.5 Million - $34.3 Million	425,000 Added 141.67%	725,000 $57.2 Million
Q2 2018 Aug 14, 2018	BUY	$37.84 - $69.96 $4.98 Million - $9.21 Million	131,635 Added 78.18%	300,000 $17.9 Million
Q1 2018 May 15, 2018	BUY	$39.82 - $57.53 $6.7 Million - $9.69 Million	168,365 New	168,365 $6.79 Million

676

162M

2.58M

2.19M

Ticker EXAS
Exchange NASDAQ
Sector Healthcare
Industry Diagnostics & Research
Shares Outstandng 176,960,000
Market Cap $10.2B
Description
Exact Sciences Corporation provides cancer screening and diagnostic test products in the United States and internationally. The company offers Cologuard, a non-invasive stool-based DNA screening test to detect DNA and hemoglobin biomarkers associated with colorectal cancer and pre-cancer. It also provides Oncotype DX, a gene expression tests for...

Get notified when there are updates to the investment portfolio of Hitchwood Capital Management LP, based on Form 13F filings with the SEC.

Stay updated on Hitchwood Capital Management LP with notifications on news.